ARTICLE
5 November 2019

OIG Work Plan Round-up: 9 New Items Added For September – October 2019, Including Medicaid Reimbursement Of Specialty Drugs

CL
Cooley LLP
Contributor
Cooley LLP logo
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law. Cooley has nearly 1,400 lawyers across 18 offices in the United States, Asia and Europe, and a total workforce of more than 3,000.
The Office of Inspector Genera for Health and Human Services Work Plan describes audits, reviews and other work statutorily required or otherwise undertaken by the OIG.
United States Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

The Office of Inspector General (OIG) for Health and Human Services (HHS) Work Plan describes audits, reviews and other work statutorily required or otherwise undertaken by the OIG. Monthly updates to the OIG Work Plan can be found on the Recently Added page. All current Work Plan items are available on the Active Work Plan Items page.

Three new items were added to the OIG Work Plan in September 2019 and six in October 2019:

Announced Agency Title Component Report Number(s)
October 2019 Centers for Medicare & Medicaid Services Review of Hospice Inpatient and Aggregate Cap Calculations Office of Audit Services W-00-19-35826
October 2019 Centers for Medicare & Medicaid Services Medicare Part B Payments for Speech-Language Pathology Office of Audit Services W-00-19-35827
October 2019 Centers for Medicare & Medicaid Services Review of Medicare Payments for Power Mobility Device Repairs Office of Audit Services W-00-19-35828
October 2019 Centers for Medicare & Medicaid Services Review of Medicare Part B Urine Drug Testing Services Office of Audit Services W-00-20-35829
October 2019 Centers for Medicare & Medicaid Services Supplier Compliance with Medicare Requirements for Replacement of Positive Airway Pressure Device Supplies Office of Audit Services W-00-20-35830
October 2019 Food and Drug Administration An Assessment of the U.S. Food and Drug Administration's Postmarket Surveillance of Medical Devices Office of Evaluation and Inspections OEI-01-19-00470
September 2019
Administration for Children and Families
ORR-Funded Facilities' Efforts to Ensure Health and Safety of Unaccompanied Children
Office of Evaluation and Inspections
OEI-09-18-00430
September 2019
Indian Health Service
Sufficiency and Implementation of Indian Health Service Patient Abuse Policies
Office of Evaluation and Inspections
OEI-06-19-00330
September 2019
Centers for Medicare & Medicaid Services
Specialty Drug Coverage and Reimbursement in Medicaid
Office of Evaluation and Inspections
OEI-03-17-00430

Health care and life sciences companies potentially impacted by these OIG Work Plan items should evaluate and consider these items carefully.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

ARTICLE
5 November 2019

OIG Work Plan Round-up: 9 New Items Added For September – October 2019, Including Medicaid Reimbursement Of Specialty Drugs

United States Food, Drugs, Healthcare, Life Sciences
Contributor
Cooley LLP logo
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law. Cooley has nearly 1,400 lawyers across 18 offices in the United States, Asia and Europe, and a total workforce of more than 3,000.
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More